Thu. 15 Feb 2024, 6:00am ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.16) by 18.75 percent. The company reported quarterly sales of $45.10 million which beat the analyst consensus estimate of $44.33 million by 1.74 percent. This is a 58.61 percent increase over sales of $28.43 million the same period last year.